In partnership with Krystal Biotech, Inc., the Decode DEB program offers no-charge genetic testing for patients with suspected dystrophic epidermolysis bullosa (DEB) and qualifying family members of patients diagnosed with DEB. This program is available to patients in the United States, including Puerto Rico. No-charge family variant testing is also available for blood relatives of patients diagnosed with pathogenic or likely pathogenic variants in COL7A1. Family variant testing must be ordered within 90 days of the initial family member’s test.
